India to United States: Lansoprazole Export Trade Route
India has recorded 442 verified shipments of Lansoprazole exported to United States, representing a combined trade value of $47.1M USD. This corridor is served by 18 active Indian exporters, with an average shipment value of $106.7K USD. The leading Indian exporter is PAR FORMULATIONS PRIVATE LIMITED, which accounts for 34% of total export value with 80 shipments worth $15.9M USD. On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer in United States with $11.6M USD in purchases. The top 3 suppliers — PAR FORMULATIONS PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Lansoprazole corridor is one of India's established pharmaceutical export routes, with 442 shipments documented worth a combined $47.1M USD. The route is dominated by PAR FORMULATIONS PRIVATE LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's lansoprazole manufacturing sector.
Across 18 active suppliers, the average shipment value stands at $106.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with lansoprazole's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #9 among India's top lansoprazole export destinations globally.
On the import side, key buyers of Indian lansoprazole in United States include MYLAN PHARMACEUTICALS INC,, EVERSANA LIFE SCIENCE SERVICES, UPS SUPPLY CHAIN SOLUTIONS INC and 49 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 25 shipments valued at $11.6M USD.
